Triple
T1103703
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Leqembi |
E25439
|
entity |
| Predicate | coDevelopedBy |
P3324
|
FINISHED |
| Object |
Eisai and Biogen
Eisai and Biogen are pharmaceutical companies that collaborate on developing innovative therapies, particularly in the field of neurodegenerative diseases such as Alzheimer’s.
|
E132619
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a49428d4448190b3b36991ceae87ce |
elicitation | completed |
| NER | batch_69a4b9c375848190baec4d534f489616 |
ner | completed |
| NED1 | batch_69ac5ea6cc888190b06f640a1e4a5147 |
ned_source_triple | completed |
| NED2 | batch_69ac633749008190bae63644d5ee7cea |
ned_description | completed |
| NEDg | batch_69ac5f15c2808190905e40c6db9d957c |
nedg | completed |
Created at: March 1, 2026, 7:43 p.m.